Rare diseases
Investigational molecules
Locations
Study of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness
GermanyStudy of Faricimab Treatment Given Every 24 Weeks in Patients with Age-Related Macular Degeneration
GermanyStudy on Long-Term Safety and Efficacy of VX-670 for Adults with Myotonic Dystrophy Type I
GermanyLong-Term Safety Study of Inhaled Pirfenidone for Patients with Progressive or Idiopathic Pulmonary Fibrosis
GermanyStudy on the Safety and Effectiveness of Patritumab Deruxtecan for Children with Relapsed or Refractory Hepatoblastoma and Rhabdomyosarcoma
GermanyStudy of Omecamtiv Mecarbil for Treating Patients with Chronic Heart Failure and Severely Reduced Heart Pumping Ability
GermanyStudy comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer
GermanyComparison of TAK-881 and HyQvia for adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
GermanyStudy Comparing Oral Azacitidine and Cedazuridine with Subcutaneous Azacitidine for Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
GermanyStudy on the Effects of CDR132L on Heart Structure and Function in Patients with Heart Failure and Left Ventricular Hypertrophy
GermanyStudy Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer
GermanyStudy Comparing Rilvegostomig with Fluoropyrimidine and Trastuzumab Deruxtecan to Standard Treatment for Patients with HER2-positive Gastric Cancer
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
